# Randomized, Crossover Safety and Pharmacokinetics Study of PT010

> **NCT02197975** · PHASE1 · COMPLETED · sponsor: **Pearl Therapeutics, Inc.** · enrollment: 20 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** PT010 Dose 1
- **DRUG:** PT010 Dose 2
- **DRUG:** Placebo MDI

## Key facts

- **NCT ID:** NCT02197975
- **Lead sponsor:** Pearl Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02197975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02197975, "Randomized, Crossover Safety and Pharmacokinetics Study of PT010". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02197975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*